<DOC>
	<DOCNO>NCT00348244</DOCNO>
	<brief_summary>Evaluate incidence sub clinical CME significantly reduce use peri-operative Acular LS plus Pred Forte compare Pred Forte alone normal cataract patient .</brief_summary>
	<brief_title>Ketorolac vs. Steroid Prevention CME</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>· Male female &gt; 18 year age schedule undergo cataract surgery surgeon expectation 20/20 BCVA postoperatively Must good general health . Patients systemic disease enrol ocular manifestation disease ( ie diabetic normal retinal exam ) Ability provide inform consent likely complete study visit · Known contraindication study medication component Uncontrolled systemic disease Required use ocular medication study medication study Abnormal preoperative OCTs obtainable Diabetic patient history macular edema diabetic retinopathy AMD patient less 20/20 surgical outcome expectation , epiretinal membrane , retinal vein occlusion , preexist macular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>